• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Intellia Therapeutics, Inc. - Common Stock (NQ:NTLA)

11.94 +0.70 (+6.23%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,937,182
Open 11.88
Bid (Size) 11.95 (2,000)
Ask (Size) 11.99 (100)
Prev. Close 11.24
Today's Range 11.47 - 12.08
52wk Range 7.950 - 28.25
Shares Outstanding 88,140,978
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Intellia Therapeutics Q2 Earnings Call Highlights ↗
August 07, 2026
Intellia Therapeutics (NASDAQ:NTLA) said it advanced its lead gene-editing programs during the second quarter, highlighting positive Phase III results for lonvo-z in hereditary angioedema and the... 
Via MarketBeat
Topics Earnings Intellectual Property
Intellia Therapeutics (NASDAQ:NTLA) Slips on Q2 Revenue Miss Despite In-Line Loss ↗
August 06, 2026
Via Chartmill

Performance

YTD
+29.6%
+29.6%
1 Month
-29.1%
-29.1%
3 Month
-15.3%
-15.3%
6 Month
-2.7%
-2.7%
1 Year
+4.2%
+4.2%

More News

Read More
News headline image
A New CRISPR "DNA Shredder" Could Change Gene-Editing -- What It Means for CRISPR Therapeutics ↗
July 08, 2026
Via The Motley Fool
News headline image
Wall Street Thinks This High-Flying Biotech Stock Can Soar Another 57% ↗
July 01, 2026
Via The Motley Fool
Intellia Therapeutics Inc (NASDAQ:NTLA) Reports Strong Q4 2025 Revenue Beat and Confirms Key 2026 Pipeline Milestones ↗
February 26, 2026
Via Chartmill
News headline image
Wall Street Expects This Growth Stock That's Already Climbed 70% to Almost Double -- And Here's Why. ↗
June 24, 2026
Via The Motley Fool
News headline image
Intellia Therapeutics vs. Omeros: Which Emerging Biotech Stock Is a Better Buy in 2026? ↗
June 20, 2026
Via The Motley Fool
News headline image
This Stock Is Up 58% This Year. Is It too Late to Buy? ↗
June 17, 2026
Via The Motley Fool
News headline image
1 Sector Warren Buffett and Greg Abel Are Largely Ignoring -- and Why Investors Shouldn't ↗
June 03, 2026
Via The Motley Fool
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
May 06, 2026
Via The Motley Fool
Topics Initial Public Offering
News headline image
3 Biotech Stocks That Could Benefit from the Patent Cliff ↗
April 27, 2026
Via MarketBeat
Topics Intellectual Property
Top movers in Friday's after hours session ↗
April 24, 2026
Via Chartmill
News headline image
2 Healthcare Stocks to Buy and 1 to Approach With Caution ↗
April 15, 2026
Via The Motley Fool
News headline image
This Cathie Wood Stock Is Up 47% This Year: Is It Too Late to Buy? ↗
March 08, 2026
Via The Motley Fool
Topics Death
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
March 03, 2026
Via The Motley Fool
News headline image
Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone
March 03, 2026
Via FinancialNewsMedia
News headline image
Why Did NTLA Stock Jump 10% In Pre-Market Today? ↗
March 02, 2026
Via Stocktwits
News headline image
Intellia (NTLA) Q4 2025 Earnings Call Transcript ↗
February 26, 2026
Via The Motley Fool
Topics Earnings
News headline image
This Cathie Wood Stock Is Already Up 41% This Year, But Is It a Buy? ↗
February 07, 2026
Via The Motley Fool
News headline image
NTLA Stock Jumped 13% Today – What Is The Latest FDA Action All About? ↗
January 27, 2026
Via Stocktwits
Nasdaq, S&P 500 Futures Edge Higher Ahead Of Long Weekend: Why NVDA, MU, NTLA, ASTS Are On Traders' Radar Today ↗
January 16, 2026
Via Stocktwits
Topics Stocks
News headline image
Cathie Wood’s ARK Made Just One Buy Last Session — And It’s A Biotech Stock Up Nearly 30% YTD ↗
January 16, 2026
Via Stocktwits
Topics Artificial Intelligence ETFs
News headline image
Intellia CEO Sells $314K in Stock While Holding Over 1 Million Shares ↗
January 12, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026
December 31, 2025
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
2 Beaten-Down Stocks That Will Soar in 2026, According to Wall Street ↗
December 29, 2025
Via The Motley Fool
Topics Death

Frequently Asked Questions

Is Intellia Therapeutics, Inc. - Common Stock publicly traded?
Yes, Intellia Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Intellia Therapeutics, Inc. - Common Stock trade on?
Intellia Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Intellia Therapeutics, Inc. - Common Stock?
The ticker symbol for Intellia Therapeutics, Inc. - Common Stock is NTLA on the Nasdaq Stock Market
What is the current price of Intellia Therapeutics, Inc. - Common Stock?
The current price of Intellia Therapeutics, Inc. - Common Stock is 11.94
When was Intellia Therapeutics, Inc. - Common Stock last traded?
The last trade of Intellia Therapeutics, Inc. - Common Stock was at 08/07/26 04:00 PM ET
What is the market capitalization of Intellia Therapeutics, Inc. - Common Stock?
The market capitalization of Intellia Therapeutics, Inc. - Common Stock is 1.05B
How many shares of Intellia Therapeutics, Inc. - Common Stock are outstanding?
Intellia Therapeutics, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap